vimarsana.com

Page 7 - Advanced Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NeoGenomics, Inc (NASDAQ:NEO) Q4 2023 Earnings Call Transcript

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript February 20, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.01. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics Fourth Quarter and Full […]

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

NeoGenomics Inc (NEO) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full Year 2023

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

NeoGenomics, Inc. (the "Company"), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 results for the period ended December 31, 2023. Highlights Fourth quarter.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.